Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M M Oken

Showing results (121-130 of 148) with videos related to

Pageof 15
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 1998
MOPP/ABV hybrid chemotherapy for advanced Hodgkin's disease significantly improves failure-free and overall survival: the 8-year results of the intergroup trialJ H Glick, M L Young, D Harrington, et al.
Blood|November 15, 1996
Prognostic implications of ploidy and proliferative activity in the diffuse, aggressive non-Hodgkin's lymphomasJ N Winter, J Andersen, D Variakojis, et al.
Haematology and Blood Transfusion|January 1, 1990
Comparison of postremission therapies in adult acute myeloid leukemia: preliminary analysis of an ECOG study. Eastern Cooperative Oncology GroupP A Cassileth, D P Harrington, J D Hines, et al.
The New England Journal of Medicine|April 8, 1993
Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphomaR I Fisher, E R Gaynor, S Dahlberg, et al.
Cancer|May 1, 1983
The influence of histologic subtype on toxicity and response to chemotherapy in non-hodgkin's lymphoma. An Eastern Cooperative Oncology Group Study utilizing the BCVP regimenM M Oken, W G Costello, G J Johnson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1994
A phase III comparison of CHOP vs. m-BACOD vs. ProMACE-CytaBOM vs. MACOP-B in patients with intermediate- or high-grade non-Hodgkin's lymphoma: results of SWOG-8516 (Intergroup 0067), the National High-Priority Lymphoma StudyR I Fisher, E R Gaynor, S Dahlberg, et al.
Blood|September 26, 2000
Acute megakaryocytic leukemia: the Eastern Cooperative Oncology Group experienceM S Tallman, D Neuberg, J M Bennett, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2000
Adjuvant active specific immunotherapy for stage II and III colon cancer with an autologous tumor cell vaccine: Eastern Cooperative Oncology Group Study E5283J E Harris, L Ryan, H C Hoover, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1993
Autologous bone marrow transplant in acute myeloid leukemia in first remissionP A Cassileth, J Andersen, H M Lazarus, et al.
Cancer Treatment Reports|February 1, 1987
Prolonged unmaintained remission after intensive consolidation therapy in adult acute nonlymphocytic leukemiaP A Cassileth, C B Begg, R Silber, et al.
Pageof 15

Showing results (121-130 of 148) with videos related to

Sort By:
Pageof 15
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 1998
MOPP/ABV hybrid chemotherapy for advanced Hodgkin's disease significantly improves failure-free and overall survival: the 8-year results of the intergroup trialJ H Glick, M L Young, D Harrington, et al.
Blood|November 15, 1996
Prognostic implications of ploidy and proliferative activity in the diffuse, aggressive non-Hodgkin's lymphomasJ N Winter, J Andersen, D Variakojis, et al.
Haematology and Blood Transfusion|January 1, 1990
Comparison of postremission therapies in adult acute myeloid leukemia: preliminary analysis of an ECOG study. Eastern Cooperative Oncology GroupP A Cassileth, D P Harrington, J D Hines, et al.
The New England Journal of Medicine|April 8, 1993
Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphomaR I Fisher, E R Gaynor, S Dahlberg, et al.
Cancer|May 1, 1983
The influence of histologic subtype on toxicity and response to chemotherapy in non-hodgkin's lymphoma. An Eastern Cooperative Oncology Group Study utilizing the BCVP regimenM M Oken, W G Costello, G J Johnson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1994
A phase III comparison of CHOP vs. m-BACOD vs. ProMACE-CytaBOM vs. MACOP-B in patients with intermediate- or high-grade non-Hodgkin's lymphoma: results of SWOG-8516 (Intergroup 0067), the National High-Priority Lymphoma StudyR I Fisher, E R Gaynor, S Dahlberg, et al.
Blood|September 26, 2000
Acute megakaryocytic leukemia: the Eastern Cooperative Oncology Group experienceM S Tallman, D Neuberg, J M Bennett, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2000
Adjuvant active specific immunotherapy for stage II and III colon cancer with an autologous tumor cell vaccine: Eastern Cooperative Oncology Group Study E5283J E Harris, L Ryan, H C Hoover, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1993
Autologous bone marrow transplant in acute myeloid leukemia in first remissionP A Cassileth, J Andersen, H M Lazarus, et al.
Cancer Treatment Reports|February 1, 1987
Prolonged unmaintained remission after intensive consolidation therapy in adult acute nonlymphocytic leukemiaP A Cassileth, C B Begg, R Silber, et al.
Pageof 15